RAFAEL HOLDINGS, INC. Payments to Acquire Marketable Securities
RAFAEL HOLDINGS, INC. (RFL) reported Payments to Acquire Marketable Securities of $6.79 million for the 12-month period ending 2024-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. payments to acquire marketable securities for the quarter ending 2024-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. payments to acquire marketable securities for the quarter ending 2024-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. payments to acquire marketable securities for the quarter ending 2024-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. payments to acquire marketable securities for the quarter ending 2023-10-31 was $6.79M.
- RAFAEL HOLDINGS, INC. payments to acquire marketable securities for fiscal 2024 was $6.79M, a 223.14% increase from fiscal 2023.
- RAFAEL HOLDINGS, INC. payments to acquire marketable securities for fiscal 2023 was $2.10M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2024-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $0.00 derived: sum of 3 quarters · filed 2025-10-29 | $6.79M 10-K · filed 2025-10-29 |
| 2024-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | $0.00 derived: sum of 2 quarters · filed 2025-06-11 | $6.79M 10-Q · filed 2025-06-11 | |
| 2024-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | $6.79M 10-Q · filed 2025-03-14 | ||
| 2023-10-31 | $6.79M 10-Q · filed 2024-12-11 | |||
| 2023-07-31 | $2.10M 10-K/A · filed 2024-12-20 | |||
| 2018-10-31 | $953.00K 10-Q · filed 2019-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |